Literature DB >> 2105769

Sudden death after treatment with pulsed methylprednisolone.

P V Gardiner1, I D Griffiths.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2105769      PMCID： PMC1661994          DOI： 10.1136/bmj.300.6717.125

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Sudden appearance of cardiac arrhythmias after dexamethasone.

Authors:  G B Schmidt; M A Meier; M S Sadove
Journal:  JAMA       Date:  1972-09-18       Impact factor: 56.272

2.  Fatal arrhythmia after pulse methylprednisolone therapy.

Authors:  R E Moses; A McCormick; W Nickey
Journal:  Ann Intern Med       Date:  1981-12       Impact factor: 25.391

3.  Sudden death after methylprednisolone pulse therapy.

Authors:  T S Bocanegra; M O Castañeda; L R Espinoza; F B Vasey; B F Germain
Journal:  Ann Intern Med       Date:  1981-07       Impact factor: 25.391

4.  Bradycardia after high-dose intravenous methylprednisolone therapy.

Authors:  N Tvede; L P Nielsen; V Andersen
Journal:  Scand J Rheumatol       Date:  1986       Impact factor: 3.641

5.  The use of high-dose pulse methylprednisolone in rheumatoid arthritis. Unproved therapy.

Authors:  M Barry
Journal:  Arch Intern Med       Date:  1985-08
  5 in total
  11 in total

1.  Fatal acute pyelonephritis following pulsed methylprednisolone for rheumatoid arthritis.

Authors:  D A Walsh; R A Durance
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

2.  Corticosteroid-induced bradycardia: Case report and review of the literature.

Authors:  Jasmine Stroeder; Charity Evans; Holly Mansell
Journal:  Can Pharm J (Ott)       Date:  2015-09

3.  Hepatic immunosuppressive effects of systemically administered novel dextran-methylprednisolone prodrugs with peptide linkers in rats.

Authors:  Imam H Shaik; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2012-07-24       Impact factor: 3.534

Review 4.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

5.  Reappraisal of Rasmussen's syndrome with special emphasis on treatment with high doses of steroids.

Authors:  D Chinchilla; O Dulac; O Robain; P Plouin; G Ponsot; J F Pinel; D Graber
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

6.  Plasma pharmacokinetics and tissue disposition of novel dextran-methylprednisolone conjugates with peptide linkers in rats.

Authors:  Suman Penugonda; Hitesh K Agarwal; Keykavous Parang; Reza Mehvar
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

7.  Effects of methylprednisolone infusions on vital signs in children with headaches.

Authors:  Elaine Heidrich; Gail Greene; Jessica Weberding; Li Lin; Susan McGee
Journal:  J Pediatr Pharmacol Ther       Date:  2013-01

8.  Attenuation of acute rejection in a rat liver transplantation model by a liver-targeted dextran prodrug of methylprednisolone.

Authors:  Anjaneya P Chimalakonda; Donald L Montgomery; Jon A Weidanz; Imam H Shaik; Justin H Nguyen; John J Lemasters; Eiji Kobayashi; Reza Mehvar
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

9.  Treatable blindness in temporal arteritis.

Authors:  J P Diamond
Journal:  Br J Ophthalmol       Date:  1991-07       Impact factor: 4.638

Review 10.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.